Please use this identifier to cite or link to this item:
http://repository.kln.ac.lk/handle/123456789/25833
Title: | RNA N6-Methyladenosine (m6A) Methyltransferase-like 3 Facilitates Tumorigenesis and Cisplatin Resistance of Arecoline-Exposed Oral Carcinoma |
Authors: | Wang, C. Kadigamuwa, C. Wu, S. Gao, Y. Chen, W. Gu, Y. Wang, S. Li, X. |
Keywords: | oral squamous cell carcinoma; arecoline; methyltransferase-like 3; cisplatin resistance; tumorigenesis |
Issue Date: | 2022 |
Publisher: | Cells |
Citation: | Wang, C.; Kadigamuwa, C.; Wu, S.; Gao, Y.; Chen,W.; Gu, Y.; Wang, S.; Li, X. RNA N6-Methyladenosine (m6A) Methyltransferase-like 3 Facilitates Tumorigenesis and Cisplatin Resistance of Arecoline-Exposed Oral Carcinoma. Cells 2022, 11, 3605. https://doi.org/10.3390/ cells11223605 |
Abstract: | Background: Arecoline is known as the main active carcinogen found in areca nut extract that drives the pathological progression of oral squamous cell carcinoma (OSCC). Studies have revealed that dysregulation of RNA N6-methyladenosine (m6A) methyltransferase components is intimately linked to cancer initiation and progression, including oral cancer. Methods: The arecoline-induced dysregulated methyltransferase-like 3 (METTL3) gene was identified using RNA-seq transcriptome assay. Using in vitro and in vivo models, the biological roles of METTL3 in arecoline-transformed oral cancer were examined. Results: We found that METTL3 was markedly elevated in arecoline-exposed OSCC cell lines and OSCC tissues of areca nut chewers. We identified that hypoxia-inducible factor 1-alpha (HIF-1↵) stimulated METTL3 expression at the transcriptional level and further proved that METTL3-MYC-HIF-1↵ formed a positive autoregulation loop in arecolinetransformed OSCC cells. Subsequently, we manifested that METTL3 depletion profoundly reduced cell proliferation, cell migration, oncogenicity, and cisplatin resistance of arecoline-exposed OSCC cells. Conclusions: Developing novel strategies to target METTL3 may be a potential way to treat OSCC patients, particularly those with areca nut chewing history and receiving cisplatin treatment. |
URI: | http://repository.kln.ac.lk/handle/123456789/25833 |
Appears in Collections: | Chemistry |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Full Paper - cells-11-03605-v4 .pdf | 973.95 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.